HHF was observed combined with CV death in the EMPA-KIDNEY trial, and failed to reach statistical significance (HR=0.84 (0.67 to 1.07)).
← all excerpts
Impact of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in patients with chronic kidney disease: propensity score matched analysis.
1
—
—